These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: A gene expression-based computational study. Liu R; Hu R; Zeng Y; Zhang W; Zhou HH EBioMedicine; 2020 Jan; 51():102602. PubMed ID: 31911269 [TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978 [TBL] [Abstract][Full Text] [Related]
12. Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer. Pinto MP; Balmaceda C; Bravo ML; Kato S; Villarroel A; Owen GI; Roa JC; Cuello MA; Ibañez C Gynecol Oncol; 2018 Oct; 151(1):10-17. PubMed ID: 30078505 [TBL] [Abstract][Full Text] [Related]
13. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer. Strickland KC; Howitt BE; Shukla SA; Rodig S; Ritterhouse LL; Liu JF; Garber JE; Chowdhury D; Wu CJ; D'Andrea AD; Matulonis UA; Konstantinopoulos PA Oncotarget; 2016 Mar; 7(12):13587-98. PubMed ID: 26871470 [TBL] [Abstract][Full Text] [Related]
14. Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer. Wouters MC; Komdeur FL; Workel HH; Klip HG; Plat A; Kooi NM; Wisman GB; Mourits MJ; Arts HJ; Oonk MH; Yigit R; de Jong S; Melief CJ; Hollema H; Duiker EW; Daemen T; de Bruyn M; Nijman HW Clin Cancer Res; 2016 Feb; 22(3):714-24. PubMed ID: 26384738 [TBL] [Abstract][Full Text] [Related]
15. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the infiltration of CD163 Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574 [TBL] [Abstract][Full Text] [Related]
17. The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy. Matsumoto Y; Mabuchi S; Kozasa K; Kuroda H; Sasano T; Yokoi E; Komura N; Sawada K; Kimura T Gynecol Oncol; 2017 Jun; 145(3):469-475. PubMed ID: 28552395 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma. Coghlan E; Meniawy TM; Munro A; Bulsara M; Stewart CJ; Tan A; Koay MHE; MaGee D; Codde J; Tan J; Salfinger SG; Mohan GR; Leung Y; Nichols CB; Cohen PA Int J Gynecol Cancer; 2017 May; 27(4):708-713. PubMed ID: 28441251 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer. Wikberg ML; Ling A; Li X; Öberg Å; Edin S; Palmqvist R Hum Pathol; 2017 Oct; 68():193-202. PubMed ID: 28882699 [TBL] [Abstract][Full Text] [Related]
20. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. Droeser RA; Hirt C; Eppenberger-Castori S; Zlobec I; Viehl CT; Frey DM; Nebiker CA; Rosso R; Zuber M; Amicarella F; Iezzi G; Sconocchia G; Heberer M; Lugli A; Tornillo L; Oertli D; Terracciano L; Spagnoli GC PLoS One; 2013; 8(5):e64814. PubMed ID: 23734221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]